AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for ...
CAMBRIDGE, England--(BUSINESS WIRE)--Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results